default author photo

Nicodemus Tedla

University of New South Wales (UNSW) - School of Medical Sciences (SoMS)

Wallace Wurth Building

Sydney, NSW 2052

Australia

SCHOLARLY PAPERS

4

DOWNLOADS

260

TOTAL CITATIONS

0

Scholarly Papers (4)

1.

Long-Term Persistence of Neutralizing Memory B Cells in SARS-CoV-2

Number of pages: 35 Posted: 25 Nov 2020
University of New South Wales (UNSW) - Kirby Institute, University of New South Wales (UNSW) - School of Medical Sciences (SoMS), University of New South Wales (UNSW) - Kirby Institute, University of New South Wales (UNSW) - School of Medical Sciences (SoMS), University of New South Wales (UNSW) - Kirby Institute, University of New South Wales (UNSW) - Kirby Institute, University of New South Wales (UNSW) - Kirby Institute, Garvan Institute of Medical Research, Garvan Institute of Medical Research, Garvan Institute of Medical Research, University of Adelaide - Viral Immunology Group, Government of New South Wales - Virology Research Laboratory, University of New South Wales (UNSW) - Kirby Institute, University of New South Wales (UNSW) - Kirby Institute, The University of Sydney - School of Medical Sciences, Northern Beaches Hospital, University of New South Wales (UNSW) - Prince of Wales Clinical School, Royal North Shore Hospital, The University of Sydney - Westmead Hospital, The University of Sydney - Westmead Hospital, University of New South Wales (UNSW) - Kirby Institute, The University of Sydney - School of Medical Sciences, The University of Sydney - School of Medical Sciences, University of New South Wales (UNSW) - School of Medical Sciences (SoMS), University of New South Wales (UNSW) - Kirby Institute, University of New South Wales (UNSW) - Kirby Institute, University of New South Wales (UNSW) - Kirby Institute and Independent
Downloads 110 (640,165)

Abstract:

Loading...

SARS-CoV-2, neutralising antibodies, RBD, memory B cells

2.

Maintenance of Broad Neutralising Antibodies and Memory B Cells 12 Months Post-Infection Is Predicted by SARS-CoV-2 Specific CD4+ T Cell Responses

Number of pages: 54 Posted: 09 Sep 2021
University of New South Wales (UNSW) - School of Medical Sciences (SoMS), University of New South Wales (UNSW) - Kirby Institute, University of New South Wales (UNSW) - Kirby Institute, University of New South Wales (UNSW) - School of Medical Sciences (SoMS), University of New South Wales (UNSW) - School of Medical Sciences (SoMS), University of New South Wales (UNSW) - Kirby Institute, University of New South Wales (UNSW), University of New South Wales (UNSW) - Kirby Institute, University of New South Wales (UNSW) - School of Medical Sciences (SoMS), University of New South Wales (UNSW) - Kirby Institute, Garvan Institute of Medical Research, Garvan Institute of Medical Research, University of New South Wales (UNSW) - Kirby Institute, University of New South Wales (UNSW) - The Kirby Institute, University of Adelaide - Viral Immunology Group, Government of New South Wales - Virology Research Laboratory, University of New South Wales (UNSW) - Kirby Institute, affiliation not provided to SSRN, University of New South Wales (UNSW) - Kirby Institute, Northern Beaches Hospital, University of New South Wales (UNSW) - Prince of Wales Clinical School, Royal North Shore Hospital, The University of Sydney - Westmead Hospital, St George Hospital, Western Sydney University, The University of Sydney - Westmead Hospital, The University of Sydney, University of New South Wales (UNSW) - Kirby Institute, University of New South Wales (UNSW) - School of Medical Sciences (SoMS), University of New South Wales (UNSW) - Kirby Institute, University of New South Wales (UNSW) - Kirby Institute and University of New South Wales (UNSW) - Kirby Institute
Downloads 64 (924,743)

Abstract:

Loading...

SARS-CoV-2, 12 months after SARS-CoV-2 infection, RBD-specific memory B cells, protection efficacy prediction, SARS-CoV-2 antibodies, SARS-CoV-2 neutralisation, variants of concern, Delta variant

3.

Affinity of the Transmitted Founder Virus Drives Early Emergence of Hepatitis C Virus Specific Neutralising Antibodies

Number of pages: 36 Posted: 27 Aug 2024
University of New South Wales (UNSW) - Kirby Institute, University of New South Wales (UNSW) - Kirby Institute, University of New South Wales (UNSW) - Kirby Institute, University of Copenhagen - Department of Immunology and Microbiology, Garvan Institute of Medical Research, University of New South Wales (UNSW) - School of Medical Sciences (SoMS), University of New South Wales (UNSW) - Kirby Institute, University of New South Wales (UNSW) - Kirby Institute, University of New South Wales (UNSW) - Kirby Institute, University of New South Wales (UNSW) - Kirby Institute, University of New South Wales (UNSW) - Kirby Institute, University of New South Wales (UNSW) - Kirby Institute, University of New South Wales (UNSW) - Kirby Institute, University of New South Wales (UNSW) - Kirby Institute, Garvan Institute of Medical Research, University of New South Wales (UNSW) - Kirby Institute, University of New South Wales (UNSW) - Kirby Institute, University of New South Wales (UNSW) - School of Medical Sciences (SoMS), University of New South Wales (UNSW) - Kirby Institute, University of New South Wales (UNSW) - Kirby Institute, University of New South Wales (UNSW) - Kirby Institute and Independent
Downloads 44 (1,133,231)

Abstract:

Loading...

hepatitis c virus, transmitted founder virus, B cell repertoire, CD4 T cells

4.

Anti-Hcv Antibodies: A Battle for Breadth and Potency

Number of pages: 10 Posted: 10 Feb 2025
affiliation not provided to SSRN, University of Melbourne, University of New South Wales (UNSW) - School of Medical Sciences (SoMS), University of Melbourne, University of New South Wales (UNSW) - Kirby Institute, affiliation not provided to SSRN and University of New South Wales (UNSW) - Kirby Institute
Downloads 42 (1,157,785)

Abstract:

Loading...

Broadly neutralizing antibodies (bNAbs)RNA virusesPotencyBreadthIC50 valuesHepatitis C virus (HCV)